When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMS - Adamas announces post-hoc data supporting benefit of Gocovri in Parkinson's
Adamas Pharmaceuticals Inc.
Adamas Pharmaceuticals (ADMS+4.5%) announces new post-hoc Phase 3 data showing that Gocovri decreased dyskinesia and OFF time (periods where levodopa therapy is not working well) in people with Parkinson’s Disease (PD).
More news on: Adamas Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,